Priya Singhal
Corporate Officer/Principal bij BIOGEN INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Priya Singhal is currently the Chief Medical Officer at Biogen, Inc. She previously worked as the Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012.
She also held a position as the Head-Research & Development at Zafgen, Inc. Dr. Singhal holds a doctorate degree from the University of Mumbai and a graduate degree from Harvard T.H.
Chan School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 02-04-2024 | 4 886 ( 0.00% ) | 1 M $ | 31-03-2024 |
Actieve functies van Priya Singhal
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 02-10-2023 |
Eerdere bekende functies van Priya Singhal
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01-01-2012 |
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Priya Singhal
| University of Mumbai | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
